A systematic review of aspirin in primary prevention: is it time for a new approach?

Am J Cardiovasc Drugs · 2015 · PMC4383813 · PMID 25502483

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significancep = 0.05actually significant

A similar effect was seen for all-cause mortality, although in one meta-analysis, the reduction in patients receiving aspirin was of borderline significance [RR 0.94 (95 % CI 0.88–1.00); p = 0.05] [ 7 ].

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.